Table 2.

Laboratory data of the subjects with CPP (n=166) divided into 2 groups by type of treatment

At start of GnRHa	Group A (n=135)	Group B (n=31)	P-value
Total E	73.14±50.85	66.63±61.40	0.216
Peak LH	12.10±11.89	9.17±5.89	0.051
IGF-1	301.89±95.76	288.86±111.14	0.157
IGF-BP3	3,247.56±804.34	3,246.83±699.80	0.997
IGF-1/IGF-BP3	0.10±0.03	0.09±0.03	0.276

Values are presented as the mean±standard deviation.

Group A, GnRHa alone group; group B, combined GnRHa/GH group; CPP, central precocious puberty; GnRHa, gonadotropin-releasing hormone agonist; E, estrogen; LH, luteinizing hormone; IGF-1, insulin-like growth factor-1; IGF-BP3, insulin-like growth factor binding protein 3.